LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
SK-BR-3 Seliciclib
0.04
uM
LJP5
 3
J06
 72
hr
 1401 4492 4223 1.0637 1.0953
SK-BR-3 Ruxolitinib
0.04
uM
LJP5
 1
O18
 72
hr
 1401 3818 4223 0.9041 0.8564
SK-BR-3 Ruxolitinib
0.04
uM
LJP5
 2
O18
 72
hr
 1401 4274 4223 1.0121 1.0180
SK-BR-3 Ruxolitinib
0.04
uM
LJP5
 3
O18
 72
hr
 1401 4637 4223 1.0980 1.1467
SK-BR-3 XL147
0.04
uM
LJP5
 1
G12
 72
hr
 1401 4488 4223 1.0627 1.0939
SK-BR-3 XL147
0.04
uM
LJP5
 2
G12
 72
hr
 1401 4710 4223 1.1153 1.1726
SK-BR-3 XL147
0.04
uM
LJP5
 3
G12
 72
hr
 1401 4787 4223 1.1335 1.1999
SK-BR-3 Saracatinib
0.04
uM
LJP6
 1
D12
 72
hr
 1401 4287 4223 1.0151 1.0227
SK-BR-3 Saracatinib
0.04
uM
LJP6
 2
D12
 72
hr
 1401 4360 4223 1.0324 1.0485
SK-BR-3 Saracatinib
0.04
uM
LJP6
 3
D12
 72
hr
 1401 4528 4223 1.0722 1.1081
SK-BR-3 Selumetinib
0.04
uM
LJP6
 1
M12
 72
hr
 1401 4700 4223 1.1129 1.1690
SK-BR-3 Selumetinib
0.04
uM
LJP6
 2
M12
 72
hr
 1401 4689 4223 1.1103 1.1651
SK-BR-3 Selumetinib
0.04
uM
LJP6
 3
M12
 72
hr
 1401 4478 4223 1.0604 1.0903
SK-BR-3 Sirolimus
0.04
uM
LJP6
 1
L18
 72
hr
 1401 2703 4223 0.6401 0.4613
SK-BR-3 Sirolimus
0.04
uM
LJP6
 2
L18
 72
hr
 1401 2701 4223 0.6396 0.4606
SK-BR-3 Sirolimus
0.04
uM
LJP6
 3
L18
 72
hr
 1401 2857 4223 0.6765 0.5158
SK-BR-3 Sorafenib
0.04
uM
LJP6
 1
B12
 72
hr
 1401 3972 4223 0.9405 0.9110
SK-BR-3 Sorafenib
0.04
uM
LJP6
 2
B12
 72
hr
 1401 3603 4223 0.8532 0.7802
SK-BR-3 Sorafenib
0.04
uM
LJP6
 3
B12
 72
hr
 1401 3981 4223 0.9427 0.9142
SK-BR-3 SU11274
0.04
uM
LJP5
 1
J12
 72
hr
 1401 3838 4223 0.9088 0.8635
SK-BR-3 SU11274
0.04
uM
LJP5
 2
J12
 72
hr
 1401 4758 4223 1.1267 1.1896
SK-BR-3 SU11274
0.04
uM
LJP5
 3
J12
 72
hr
 1401 4891 4223 1.1582 1.2367
SK-BR-3 Fedratinib
0.04
uM
LJP5
 1
L06
 72
hr
 1401 4335 4223 1.0265 1.0397
SK-BR-3 Fedratinib
0.04
uM
LJP5
 2
L06
 72
hr
 1401 4604 4223 1.0902 1.1350
SK-BR-3 Fedratinib
0.04
uM
LJP5
 3
L06
 72
hr
 1401 4516 4223 1.0694 1.1038